KINGDON CAPITAL MANAGEMENT, L.L.C. - Q1 2019 holdings

$748 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 61 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 88.1% .

 Value Shares↓ Weighting
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$43,454,000
+75.2%
844,266
+25.9%
5.81%
+55.3%
GOOGL NewALPHABET INCcap stk cl a$34,772,00029,546
+100.0%
4.65%
MIDD NewMIDDLEBY CORP$34,130,000262,481
+100.0%
4.56%
ARGX SellARGENX SEsponsored adr$33,775,000
+21.2%
270,548
-6.8%
4.52%
+7.4%
MSFT BuyMICROSOFT CORP$31,852,000
+24.7%
270,067
+7.4%
4.26%
+10.5%
NSC NewNORFOLK SOUTHERN CORP$28,404,000151,980
+100.0%
3.80%
ERI BuyELDORADO RESORTS INC$27,928,000
+232.1%
598,167
+157.6%
3.73%
+194.5%
HRTX BuyHERON THERAPEUTICS INC$26,595,000
-3.3%
1,088,166
+2.6%
3.56%
-14.3%
RCL BuyROYAL CARIBBEAN CRUISES LTD$25,605,000
+61.6%
223,393
+37.8%
3.42%
+43.2%
AMZN BuyAMAZON COM INC$23,992,000
+55.3%
13,473
+31.0%
3.21%
+37.7%
CELG NewCELGENE CORP$23,985,000254,244
+100.0%
3.21%
CP SellCANADIAN PAC RY LTD$21,740,000
+1.6%
105,521
-12.4%
2.91%
-9.9%
BSX NewBOSTON SCIENTIFIC CORP$21,594,000562,641
+100.0%
2.89%
TPX  TEMPUR SEALY INTL INC$20,433,000
+39.3%
354,3090.0%2.73%
+23.5%
KEYS SellKEYSIGHT TECHNOLOGIES INC$20,212,000
-10.5%
231,794
-36.3%
2.70%
-20.6%
CSTM SellCONSTELLIUM NVcl a$16,503,000
+7.5%
2,068,005
-5.8%
2.21%
-4.7%
RH SellRH$16,398,000
-39.3%
159,285
-29.3%
2.19%
-46.2%
TSN NewTYSON FOODS INCcl a$15,777,000227,230
+100.0%
2.11%
TMO NewTHERMO FISHER SCIENTIFIC INC$15,767,00057,603
+100.0%
2.11%
LGFA BuyLIONS GATE ENTMNT CORPcl a vtg$15,662,000
+21.6%
1,001,427
+25.2%
2.09%
+7.8%
IQV NewIQVIA HLDGS INC$14,927,000103,768
+100.0%
2.00%
LW NewLAMB WESTON HLDGS INC$14,708,000196,260
+100.0%
1.97%
TECK NewTECK RESOURCES LTDcl b$12,730,000549,191
+100.0%
1.70%
MRVL SellMARVELL TECHNOLOGY GROUP LTDord$12,391,000
+8.6%
622,979
-11.6%
1.66%
-3.7%
CRM SellSALESFORCE COM INC$12,273,000
-39.8%
77,494
-47.9%
1.64%
-46.6%
NOMD SellNOMAD FOODS LTD$11,295,000
-16.3%
552,317
-31.5%
1.51%
-25.8%
ICPT NewINTERCEPT PHARMACEUTICALS INput$11,186,000100,000
+100.0%
1.50%
FLXN BuyFLEXION THERAPEUTICS INC$11,033,000
+66.9%
884,018
+51.4%
1.48%
+47.9%
CCJ BuyCAMECO CORP$9,699,000
+8.1%
822,683
+4.1%
1.30%
-4.1%
EW NewEDWARDS LIFESCIENCES CORPput$9,567,00050,000
+100.0%
1.28%
WSC BuyWILLSCOT CORP$8,944,000
+18.0%
806,476
+0.2%
1.20%
+4.6%
ASH BuyASHLAND GLOBAL HLDGS INC$8,831,000
+10.4%
113,025
+0.3%
1.18%
-2.1%
ZBH BuyZIMMER BIOMET HLDGS INC$8,399,000
+24.6%
65,775
+1.2%
1.12%
+10.4%
AMLP BuyALPS ETF TRalerian mlp$8,160,000
+91.3%
813,561
+66.5%
1.09%
+69.7%
IONS NewIONIS PHARMACEUTICALS INCput$8,117,000100,000
+100.0%
1.08%
LSCC BuyLATTICE SEMICONDUCTOR CORP$7,975,000
+87.3%
668,468
+8.6%
1.07%
+66.0%
IFRX NewINFLARX NV$6,629,000175,414
+100.0%
0.89%
ATNX BuyATHENEX INC$6,594,000
+29.6%
538,291
+34.3%
0.88%
+15.0%
TROX NewTRONOX HOLDINGS PLC$6,512,000495,195
+100.0%
0.87%
FGEN NewFIBROGEN INCput$5,435,000100,000
+100.0%
0.73%
SESN  SESEN BIO INC$5,397,000
-27.5%
5,239,5570.0%0.72%
-35.7%
GEC  GREAT ELM CAP GROUP INC$5,385,000
+25.7%
1,267,0300.0%0.72%
+11.5%
BHVN NewBIOHAVEN PHARMACTL HLDG CO Lcall$5,147,000100,000
+100.0%
0.69%
RPD NewRAPID7 INC$5,061,000100,000
+100.0%
0.68%
DOCU NewDOCUSIGN INC$4,399,00084,864
+100.0%
0.59%
DCPH NewDECIPHERA PHARMACEUTICALS IN$4,294,000184,994
+100.0%
0.57%
BOLD  AUDENTES THERAPEUTICS INC$4,215,000
+83.0%
108,0310.0%0.56%
+62.5%
HRTX NewHERON THERAPEUTICS INCcall$3,666,000150,000
+100.0%
0.49%
MTEM  MOLECULAR TEMPLATES INC$2,988,000
+43.9%
514,2250.0%0.40%
+27.5%
TMQ NewTRILOGY METALS INC NEW$2,470,0001,004,135
+100.0%
0.33%
MITO NewSTEALTH BIOTHERAPEUTICS CORPsponsored ads$2,284,000178,453
+100.0%
0.30%
SLGL  SOL GEL TECHNOLOGIES$1,624,000
+12.5%
239,9490.0%0.22%
-0.5%
METC SellRAMACO RES INC$1,602,000
-30.4%
276,246
-40.6%
0.21%
-38.3%
 KEMPHARM INCnote 5.500% 2/0$1,496,000
-0.9%
3,000,0000.0%0.20%
-12.3%
OSW NewONESPAWORLD HOLDINGS LIMITED$1,417,000103,756
+100.0%
0.19%
XLP  SELECT SECTOR SPDR TRsbi cons stpls$550,000
+10.4%
9,8000.0%0.07%
-1.3%
IMGN BuyIMMUNOGEN INCcall$542,000
+12.9%
200,000
+100.0%
0.07%0.0%
LYFT NewLYFT INC$431,0005,500
+100.0%
0.06%
DELL NewDELL TECHNOLOGIES INCcl c$414,0007,050
+100.0%
0.06%
DESTQ BuyDESTINATION MATERNITY CORP$381,000
+24.9%
174,816
+62.6%
0.05%
+10.9%
GTYHW NewGTY TECHNOLOGY HOLDINGS INC*w exp 02/19/202$241,000400,000
+100.0%
0.03%
CLVS ExitCLOVIS ONCOLOGY INC$0-1,600
-100.0%
-0.00%
GTYHW ExitGTY TECHNOLOGY HOLDINGS INC*w exp 10/25/202$0-400,000
-100.0%
-0.05%
CLVS ExitCLOVIS ONCOLOGY INCcall$0-50,000
-100.0%
-0.14%
ExitINSMED INCnote 1.750% 1/1$0-2,000,000
-100.0%
-0.22%
GIS ExitGENERAL MLS INCcall$0-100,000
-100.0%
-0.59%
CSX ExitCSX CORP$0-66,000
-100.0%
-0.62%
TTWO ExitTAKE-TWO INTERACTIVE SOFTWAR$0-40,000
-100.0%
-0.62%
ExitCLOVIS ONCOLOGY INCnote 2.500% 9/1$0-6,000,000
-100.0%
-0.76%
TME ExitTENCENT MUSIC ENTMT GROUPspon ads$0-513,832
-100.0%
-1.02%
MDT ExitMEDTRONIC PLC$0-84,720
-100.0%
-1.16%
IGT ExitINTERNATIONAL GAME TECHNOLOG$0-537,023
-100.0%
-1.18%
ARRY ExitARRAY BIOPHARMA INC$0-569,298
-100.0%
-1.22%
MRVL ExitMARVELL TECHNOLOGY GROUP LTDcall$0-510,000
-100.0%
-1.24%
ExitLIBERTY MEDIA CORPdeb 4.000%11/1$0-14,000,000
-100.0%
-1.41%
CNC ExitCENTENE CORP DEL$0-88,042
-100.0%
-1.53%
FTV ExitFORTIVE CORP$0-157,409
-100.0%
-1.61%
CI ExitCIGNA CORP NEW$0-59,631
-100.0%
-1.71%
UAL ExitUNITED CONTL HLDGS INC$0-148,629
-100.0%
-1.88%
DE ExitDEERE & CO$0-85,937
-100.0%
-1.93%
SAGE ExitSAGE THERAPEUTICS INC$0-146,179
-100.0%
-2.11%
MPC ExitMARATHON PETE CORP$0-245,745
-100.0%
-2.19%
SHW ExitSHERWIN WILLIAMS CO$0-47,310
-100.0%
-2.81%
XBI ExitSPDR SERIES TRUSTcall$0-400,000
-100.0%
-4.33%
BG ExitBUNGE LIMITED$0-685,145
-100.0%
-5.52%
XLF ExitSELECT SECTOR SPDR TRcall$0-1,959,200
-100.0%
-7.04%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
FLEXION THERAPEUTICS INC30Q2 20213.1%
SPDR S&P 500 ETF TR29Q3 202334.8%
ISHARES TR27Q3 202313.2%
HERON THERAPEUTICS INC23Q3 20194.2%
SOL GEL TECHNOLOGIES23Q3 20231.5%
META PLATFORMS INC22Q3 20235.9%
LIBERTY MEDIA CORP21Q4 20181.4%
NOMAD HLDGS LTD19Q3 20202.1%
AMAZON COM INC18Q3 20227.6%
SPDR SER TR18Q3 20235.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
KINGDON CAPITAL MANAGEMENT, L.L.C. Q1 2019 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Praxis Precision Medicines, Inc.January 25, 20232,855,9896.1%
GTY Technology Holdings Inc.February 10, 20201,598,2123.1%
Jaguar Health, Inc.February 10, 20202700.0%
Sesen Bio, Inc.February 10, 20204,040,8353.9%
Eleven Biotherapeutics, Inc.April 04, 20182,213,9805.1%
AIT Therapeutics, Inc.April 02, 2018400,8594.8%
FATE THERAPEUTICS INCSold outFebruary 14, 201800.0%
Great Elm Capital Group, Inc.February 14, 20181,267,0305.0%
HERON THERAPEUTICS, INC. /DE/February 14, 20182,179,6203.4%
Horizon Pharma plcSold outFebruary 14, 201800.0%

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR/A2024-03-18
13F-HR2024-02-14
SC 13G/A2024-02-06
SC 13G/A2024-02-06
SC 13G/A2023-11-29
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G2023-04-13

View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (747989000.0 != 747987000.0)

Export KINGDON CAPITAL MANAGEMENT, L.L.C.'s holdings